by Josh Barney, University of Virginia Research from UVA’s Jogender Tushir-Singh explains why antibody approaches effectively killed cancer tumors in lab tests but proved ineffective in people. Credit: Dan Addison, University Communications New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed...
